Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06131398
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-11-09
Brief Title:
A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Sponsor:
Amgen
Organization:
Amgen